IGF-1 LR3 1mg Peptide: Research Material Overview
Long R3 IGF-1 is an engineered insulin-like growth factor analogue used in receptor-signaling and protein-expression research. Published studies include recombinant production, cell models and animal models. Findings from these systems cannot be assumed to demonstrate human safety or efficacy.
Product specifications
| Catalog name | IGF-1 LR3 1mg Peptide |
|---|---|
| SKU | BP-11715 |
| Category | Growth-Factor Research, Tissue-Pathway Research, Peptides |
| Format | Sealed research material; refer to the product label and listing image for the labeled quantity |
| Intended use | Controlled laboratory and in-vitro research only |
Research context and evidence limits
Compound names can appear across biochemical, cell-culture, animal and clinical publications, but the strength and applicability of evidence differ substantially by model. Researchers should review the complete methods and limitations of each source rather than treating a paper title or isolated endpoint as a product claim.
Commercial catalog material is not automatically equivalent to a pharmaceutical preparation used in a published study. Product identity, lot documentation, analytical method and protocol controls must be evaluated independently.
Selected research literature
- Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris. (PubMed 37261455, 2023 Jul)
- Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice. (PubMed 39610283, 2025 Jan)
- Action of long(R3)-insulin-like growth factor-1 on protein metabolism in beef heifers. (PubMed 10370861, 1999 May)
Related BioPharma resources
Frequently asked questions
What is IGF-1 LR3?
Long R3 IGF-1 is an engineered insulin-like growth factor analogue used in receptor-signaling and protein-expression research. Published studies include recombinant production, cell models and animal models. Findings from these systems cannot be assumed to demonstrate human safety or efficacy.
Do published studies establish approved use?
No. The linked sources are provided for scientific context. They do not establish that this catalog item is safe, effective or approved for use in humans or animals.
Does BioPharma provide dosing or administration guidance?
No. BioPharma does not provide dosing, administration or human-use instructions.
Reviews
There are no reviews yet.